Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 Jul;42(1):162–167. doi: 10.1038/bjc.1980.216

Effects of BCG and 1-(4-amino-2-methyl-5-pyrimidinyl)-methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) on the cytostatic activity of macrophages in normal and tumour-bearing rats.

N Saijo, N Irimajiri, A Ozaki, E Shimizu, H Niitani
PMCID: PMC2010464  PMID: 7000114

Full text

PDF
162

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Currie G. A., Basham C. Activated macrophages release a factor which lyses malignant cells but not normal cells. J Exp Med. 1975 Dec 1;142(6):1600–1605. doi: 10.1084/jem.142.6.1600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hosokawa M., Sendo F., Gotoda E., Kobayashi H. Combination of immunotherapy and chemotherapy to experimental tumors in rats. Gan. 1971 Feb;62(1):57–60. [PubMed] [Google Scholar]
  3. Keller R. Mechanisms by which activated normal macrophages destroy syngeneic rat tumour cells in vitro. Cytokinetics, non-involvement of T lymphocytes, and effect of metabolic inhibitors. Immunology. 1974 Aug;27(2):285–298. [PMC free article] [PubMed] [Google Scholar]
  4. Li J., Mansfield M., Wallace J. H. Tumoristatic effects of nonimmune BALB/c peritoneal macrophages on syngeneic lymphoma cells in vitro. Oncology. 1977;34(6):245–250. doi: 10.1159/000225234. [DOI] [PubMed] [Google Scholar]
  5. Saijo N., Niitani H., Chikama M., Taniguchi T., Kimura K. Effect of Propionibacterium acnes or BCG on enzyme activities in spleen lymphocytes of Donryu strain rats. Gan. 1978 Jun;69(3):345–352. [PubMed] [Google Scholar]
  6. Saijo N., Niitani H., Irimajiri N., Chikama M. Effect of 1(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) on Sato lung carcinoma (SLC). Preliminary result of immunochemotherapy for SLC by combination of ACNU and Propionibacterium acnes. Oncology. 1979;36(1):7–10. doi: 10.1159/000225309. [DOI] [PubMed] [Google Scholar]
  7. Sarna G. P., Lowitz B. B., Haskell C. M., Dorey F. J., Cline M. J. Chemo-immunotherapy for unresectable bronchogenic carcinoma. Cancer Treat Rep. 1978 May;62(5):681–687. [PubMed] [Google Scholar]
  8. Schultz R. M., Papamatheakis J. D., Luetzeler J., Chirigos M. A. Association of macrophage activation with antitumor activity by synthetic and biological agents. Cancer Res. 1977 Sep;37(9):3338–3343. [PubMed] [Google Scholar]
  9. Williams R. M., Germain R. N., Benacerraf B. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells. J Natl Cancer Inst. 1975 Mar;54(3):697–708. [PubMed] [Google Scholar]
  10. Yamamura Y., Sakatani M., Ogura T., Azuma I. Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS). Cancer. 1979 Apr;43(4):1314–1319. doi: 10.1002/1097-0142(197904)43:4<1314::aid-cncr2820430420>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES